{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T20:30:09Z","timestamp":1744317009470,"version":"3.37.3"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,10,17]],"date-time":"2022-10-17T00:00:00Z","timestamp":1665964800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,10,17]],"date-time":"2022-10-17T00:00:00Z","timestamp":1665964800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81700076","81602608"],"award-info":[{"award-number":["81700076","81602608"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Medical Scientific Research Foundation of Guangdong","award":["A2019466"],"award-info":[{"award-number":["A2019466"]}]},{"DOI":"10.13039\/501100005725","name":"National Plan for Science, Technology and Innovation","doi-asserted-by":"publisher","award":["201905010004"],"award-info":[{"award-number":["201905010004"]}],"id":[{"id":"10.13039\/501100005725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s00280-022-04481-9","type":"journal-article","created":{"date-parts":[[2022,10,17]],"date-time":"2022-10-17T10:02:39Z","timestamp":1666000959000},"page":"455-465","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Disulfiram enhances chemotherapeutic effects of doxorubicin liposomes against human hepatocellular carcinoma via activating ROS-induced cell stress response pathways"],"prefix":"10.1007","volume":"90","author":[{"given":"Hai","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengjie","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingting","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yihan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaochun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinke","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5622-8918","authenticated-orcid":false,"given":"Zhiyuan","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,10,17]]},"reference":[{"issue":"6","key":"4481_CR1","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1039\/c5tx00210a","volume":"4","author":"PE Tawari","year":"2015","unstructured":"Tawari PE, Wang Z, Najlah M, Tsang CW, Kannappan V, Liu P, McConville C, He B, Armesilla AL, Wang W (2015) The cytotoxic mechanisms of disulfiram and copper(ii) in cancer cells. Toxicol Res (Camb) 4(6):1439\u20131442. https:\/\/doi.org\/10.1039\/c5tx00210a","journal-title":"Toxicol Res (Camb)"},{"key":"4481_CR2","doi-asserted-by":"publisher","first-page":"108727","DOI":"10.1016\/j.biopha.2019.108727","volume":"113","author":"Z Yang","year":"2019","unstructured":"Yang Z, Guo F, Albers AE, Sehouli J, Kaufmann AM (2019) Disulfiram modulates ROS accumulation and overcomes synergistically cisplatin resistance in breast cancer cell lines. Biomed Pharmacother 113:108727. https:\/\/doi.org\/10.1016\/j.biopha.2019.108727","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"4481_CR3","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s00280-020-04216-8","volume":"87","author":"C Lu","year":"2021","unstructured":"Lu C, Li X, Ren Y, Zhang X (2021) Disulfiram: a novel repurposed drug for cancer therapy. Cancer Chemother Pharmacol 87(2):159\u2013172. https:\/\/doi.org\/10.1007\/s00280-020-04216-8","journal-title":"Cancer Chemother Pharmacol"},{"issue":"1","key":"4481_CR4","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.canlet.2015.07.029","volume":"369","author":"Y Li","year":"2015","unstructured":"Li Y, Fu SY, Wang LH, Wang FY, Wang NN, Cao Q, Wang YT, Yang JY, Wu CF (2015) Copper improves the anti-angiogenic activity of disulfiram through the EGFR\/Src\/VEGF pathway in gliomas. Cancer Lett 369(1):86\u201396. https:\/\/doi.org\/10.1016\/j.canlet.2015.07.029","journal-title":"Cancer Lett"},{"issue":"6","key":"4481_CR5","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1021\/mp049917l","volume":"1","author":"TW Loo","year":"2004","unstructured":"Loo TW, Bartlett MC, Clarke DM (2004) Disulfiram metabolites permanently inactivate the human multidrug resistance P-glycoprotein. Mol Pharm 1(6):426\u2013433. https:\/\/doi.org\/10.1021\/mp049917l","journal-title":"Mol Pharm"},{"key":"4481_CR6","doi-asserted-by":"publisher","first-page":"683695","DOI":"10.3389\/fonc.2021.683695","volume":"11","author":"Y Xu","year":"2021","unstructured":"Xu Y, Lu L, Luo J, Wang L, Zhang Q, Cao J, Jiao Y (2021) Disulfiram alone functions as a radiosensitizer for pancreatic cancer both in vitro and in vivo. Front Oncol 11:683695. https:\/\/doi.org\/10.3389\/fonc.2021.683695","journal-title":"Front Oncol"},{"issue":"20","key":"4481_CR7","first-page":"4380","volume":"20","author":"O Celik","year":"2016","unstructured":"Celik O, Ersahin A, Acet M, Celik N, Baykus Y, Deniz R, Ozerol E, Ozerol I (2016) Disulfiram, as a candidate NF-kappaB and proteasome inhibitor, prevents endometriotic implant growing in a rat model of endometriosis. Eur Rev Med Pharmacol Sci 20(20):4380\u20134389","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"7684","key":"4481_CR8","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/nature25016","volume":"552","author":"Z Skrott","year":"2017","unstructured":"Skrott Z, Mistrik M, Andersen KK, Friis S, Majera D, Gursky J, Ozdian T, Bartkova J, Turi Z, Moudry P, Kraus M, Michalova M, Vaclavkova J, Dzubak P, Vrobel I, Pouckova P, Sedlacek J, Miklovicova A, Kutt A, Li J, Mattova J, Driessen C, Dou QP, Olsen J, Hajduch M, Cvek B, Deshaies RJ, Bartek J (2017) Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4. Nature 552(7684):194\u2013199. https:\/\/doi.org\/10.1038\/nature25016","journal-title":"Nature"},{"issue":"40","key":"4481_CR9","doi-asserted-by":"publisher","first-page":"6711","DOI":"10.1038\/s41388-019-0915-2","volume":"38","author":"Z Skrott","year":"2019","unstructured":"Skrott Z, Majera D, Gursky J, Buchtova T, Hajduch M, Mistrik M, Bartek J (2019) Disulfiram\u2019s anti-cancer activity reflects targeting NPL4, not inhibition of aldehyde dehydrogenase. Oncogene 38(40):6711\u20136722. https:\/\/doi.org\/10.1038\/s41388-019-0915-2","journal-title":"Oncogene"},{"issue":"1","key":"4481_CR10","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/s41467-020-14338-5","volume":"11","author":"Y Terashima","year":"2020","unstructured":"Terashima Y, Toda E, Itakura M, Otsuji M, Yoshinaga S, Okumura K, Shand FHW, Komohara Y, Takeda M, Kokubo K, Chen MC, Yokoi S, Rokutan H, Kofuku Y, Ohnishi K, Ohira M, Iizasa T, Nakano H, Okabe T, Kojima H, Shimizu A, Kanegasaki S, Zhang MR, Shimada I, Nagase H, Terasawa H, Matsushima K (2020) Targeting FROUNT with disulfiram suppresses macrophage accumulation and its tumor-promoting properties. Nat Commun 11(1):609. https:\/\/doi.org\/10.1038\/s41467-020-14338-5","journal-title":"Nat Commun"},{"key":"4481_CR11","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.semcancer.2018.06.001","volume":"53","author":"X Qian","year":"2018","unstructured":"Qian X, Nie X, Yao W, Klinghammer K, Sudhoff H, Kaufmann AM, Albers AE (2018) Reactive oxygen species in cancer stem cells of head and neck squamous cancer. Semin Cancer Biol 53:248\u2013257. https:\/\/doi.org\/10.1016\/j.semcancer.2018.06.001","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"4481_CR12","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12964-019-0507-3","volume":"18","author":"T Sun","year":"2020","unstructured":"Sun T, Yang W, Toprani SM, Guo W, He L, DeLeo AB, Ferrone S, Zhang G, Wang E, Lin Z, Hu P, Wang X (2020) Induction of immunogenic cell death in radiation-resistant breast cancer stem cells by repurposing anti-alcoholism drug disulfiram. Cell Commun Signal 18(1):36. https:\/\/doi.org\/10.1186\/s12964-019-0507-3","journal-title":"Cell Commun Signal"},{"key":"4481_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/1320201","volume":"2019","author":"JB Mandell","year":"2019","unstructured":"Mandell JB, Lu F, Fisch M, Beumer JH, Guo J, Watters RJ, Weiss KR (2019) Combination therapy with disulfiram, copper, and doxorubicin for osteosarcoma: in vitro support for a novel drug repurposing strategy. Sarcoma 2019:1\u20139. https:\/\/doi.org\/10.1155\/2019\/1320201","journal-title":"Sarcoma"},{"issue":"7","key":"4481_CR14","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1039\/c8bm00271a","volume":"6","author":"X Tao","year":"2018","unstructured":"Tao X, Gou J, Zhang Q, Tan X, Ren T, Yao Q, Tian B, Kou L, Zhang L, Tang X (2018) Synergistic breast tumor cell killing achieved by intracellular co-delivery of doxorubicin and disulfiram via core-shell-corona nanoparticles. Biomater Sci 6(7):1869\u20131881. https:\/\/doi.org\/10.1039\/c8bm00271a","journal-title":"Biomater Sci"},{"issue":"7","key":"4481_CR15","doi-asserted-by":"publisher","first-page":"5858","DOI":"10.1021\/nn4010796","volume":"7","author":"X Duan","year":"2013","unstructured":"Duan X, Xiao J, Yin Q, Zhang Z, Yu H, Mao S, Li Y (2013) Smart pH-sensitive and temporal-controlled polymeric micelles for effective combination therapy of doxorubicin and disulfiram. ACS Nano 7(7):5858\u20135869. https:\/\/doi.org\/10.1021\/nn4010796","journal-title":"ACS Nano"},{"key":"4481_CR16","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/j.1600-0447.1992.tb03310.x","volume":"369","author":"B Johansson","year":"1992","unstructured":"Johansson B (1992) A review of the pharmacokinetics and pharmacodynamics of disulfiram and its metabolites. Acta Psychiatr Scand Suppl 369:15\u201326. https:\/\/doi.org\/10.1111\/j.1600-0447.1992.tb03310.x","journal-title":"Acta Psychiatr Scand Suppl"},{"issue":"3","key":"4481_CR17","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1124\/pr.58.3.10","volume":"58","author":"TC Chou","year":"2006","unstructured":"Chou TC (2006) Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacol Rev 58(3):621\u2013681. https:\/\/doi.org\/10.1124\/pr.58.3.10","journal-title":"Pharmacol Rev"},{"issue":"3","key":"4481_CR18","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/S0022-2836(05)80360-2","volume":"215","author":"SF Altschul","year":"1990","unstructured":"Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ (1990) Basic local alignment search tool. J Mol Biol 215(3):403\u2013410. https:\/\/doi.org\/10.1016\/S0022-2836(05)80360-2","journal-title":"J Mol Biol"},{"key":"4481_CR19","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jconrel.2016.07.028","volume":"238","author":"R Ngoune","year":"2016","unstructured":"Ngoune R, Peters A, von Elverfeldt D, Winkler K, Putz G (2016) Accumulating nanoparticles by EPR: a route of no return. J Control Release 238:58\u201370. https:\/\/doi.org\/10.1016\/j.jconrel.2016.07.028","journal-title":"J Control Release"},{"issue":"1","key":"4481_CR20","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3390\/cells11010114","volume":"11","author":"X Sun","year":"2021","unstructured":"Sun X, Siri S, Hurst A, Qiu H (2021) Heat shock protein 22 in physiological and pathological hearts: small molecule. Large Potentials Cells 11(1):114. https:\/\/doi.org\/10.3390\/cells11010114","journal-title":"Large Potentials Cells"},{"issue":"1","key":"4481_CR21","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s10522-015-9591-y","volume":"17","author":"G Morrow","year":"2016","unstructured":"Morrow G, Le Pecheur M, Tanguay RM (2016) Drosophila melanogaster mitochondrial Hsp22: a role in resistance to oxidative stress, aging and the mitochondrial unfolding protein response. Biogerontology 17(1):61\u201370. https:\/\/doi.org\/10.1007\/s10522-015-9591-y","journal-title":"Biogerontology"},{"issue":"12","key":"4481_CR22","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.15252\/embr.201439246","volume":"15","author":"MW Pickup","year":"2014","unstructured":"Pickup MW, Mouw JK, Weaver VM (2014) The extracellular matrix modulates the hallmarks of cancer. EMBO Rep 15(12):1243\u20131253. https:\/\/doi.org\/10.15252\/embr.201439246","journal-title":"EMBO Rep"},{"issue":"24","key":"4481_CR23","first-page":"6091","volume":"59","author":"MJ Riemenschneider","year":"1999","unstructured":"Riemenschneider MJ, Buschges R, Wolter M, Reifenberger J, Bostrom J, Kraus JA, Schlegel U, Reifenberger G (1999) Amplification and overexpression of the MDM4 (MDMX) gene from 1q32 in a subset of malignant gliomas without TP53 mutation or MDM2 amplification. Cancer Res 59(24):6091\u20136096","journal-title":"Cancer Res"},{"issue":"13","key":"4481_CR24","doi-asserted-by":"publisher","first-page":"5835","DOI":"10.1128\/MCB.24.13.5835-5843.2004","volume":"24","author":"D Danovi","year":"2004","unstructured":"Danovi D, Meulmeester E, Pasini D, Migliorini D, Capra M, Frenk R, de Graaf P, Francoz S, Gasparini P, Gobbi A, Helin K, Pelicci PG, Jochemsen AG, Marine JC (2004) Amplification of Mdmx (or Mdm4) directly contributes to tumor formation by inhibiting p53 tumor suppressor activity. Mol Cell Biol 24(13):5835\u20135843. https:\/\/doi.org\/10.1128\/MCB.24.13.5835-5843.2004","journal-title":"Mol Cell Biol"},{"issue":"1","key":"4481_CR25","doi-asserted-by":"publisher","first-page":"a000968","DOI":"10.1101\/cshperspect.a000968","volume":"2","author":"ME Perry","year":"2010","unstructured":"Perry ME (2010) The regulation of the p53-mediated stress response by MDM2 and MDM4. Cold Spring Harb Perspect Biol 2(1):a000968. https:\/\/doi.org\/10.1101\/cshperspect.a000968","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"1","key":"4481_CR26","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1172\/jci82534","volume":"126","author":"M Dewaele","year":"2016","unstructured":"Dewaele M, Tabaglio T, Willekens K, Bezzi M, Teo SX, Low DH, Koh CM, Rambow F, Fiers M, Rogiers A, Radaelli E, Al-Haddawi M, Tan SY, Hermans E, Amant F, Yan H, Lakshmanan M, Koumar RC, Lim ST, Derheimer FA, Campbell RM, Bonday Z, Tergaonkar V, Shackleton M, Blattner C, Marine JC, Guccione E (2016) Antisense oligonucleotide-mediated MDM4 exon 6 skipping impairs tumor growth. J Clin Invest 126(1):68\u201384. https:\/\/doi.org\/10.1172\/jci82534","journal-title":"J Clin Invest"},{"issue":"8","key":"4481_CR27","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1038\/nm.2863","volume":"18","author":"A Gembarska","year":"2012","unstructured":"Gembarska A, Luciani F, Fedele C, Russell EA, Dewaele M, Villar S, Zwolinska A, Haupt S, de Lange J, Yip D, Goydos J, Haigh JJ, Haupt Y, Larue L, Jochemsen A, Shi H, Moriceau G, Lo RS, Ghanem G, Shackleton M, Bernal F, Marine JC (2012) MDM4 is a key therapeutic target in cutaneous melanoma. Nat Med 18(8):1239\u20131247. https:\/\/doi.org\/10.1038\/nm.2863","journal-title":"Nat Med"},{"issue":"27","key":"4481_CR28","doi-asserted-by":"publisher","first-page":"18821","DOI":"10.18632\/oncotarget.24568","volume":"9","author":"K Goto","year":"2018","unstructured":"Goto K, Arai J, Stephanou A, Kato N (2018) Novel therapeutic features of disulfiram against hepatocellular carcinoma cells with inhibitory effects on a disintegrin and metalloproteinase 10. Oncotarget 9(27):18821\u201318831. https:\/\/doi.org\/10.18632\/oncotarget.24568","journal-title":"Oncotarget"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-022-04481-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00280-022-04481-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-022-04481-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,5]],"date-time":"2022-11-05T10:09:04Z","timestamp":1667642944000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00280-022-04481-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,17]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["4481"],"URL":"https:\/\/doi.org\/10.1007\/s00280-022-04481-9","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"type":"print","value":"0344-5704"},{"type":"electronic","value":"1432-0843"}],"subject":[],"published":{"date-parts":[[2022,10,17]]},"assertion":[{"value":"17 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There are no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All experimental protocols were approved by the Ethics Committee of The Fifth Affiliated Hospital of Guangzhou Medical University. This study was conducted in accordance with the Declaration of Helsinki. All methods were carried out in accordance with relevant guidelines and regulations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}